The authors showed co-localisation of CD147 and CD44v3-10 with MDR1 and MCTs in tumour and stromal cells, suggesting a role for these invasive markers in the regulation of drug resistance in the progression of PCa. The gene discussed is BSG; the disease is neoplasm.